Recent evidence indicates that circulating clusterin levels are closely associated with cardiometabolic risk parameters, suggesting that elevated CLU may represent a stress-responsive or compensatory biomarker accompanying metabolic dysregulation, including insulin resistance, rather than a direct causal mediator [11]. Here, CLU is linked to Insulin resistance.